FDA Inspection 1303442 - New York Blood Center Enterprises - February 19, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns New York Blood Center Enterprises, with an inspection on February 19, 2026, issued by the New York District Office, covering biologics.

Company: New York Blood Center Enterprises
Inspection Date: February 19, 2026
Product Type: Biologics
Office: New York District Office

Open in Dashboard

ID · 6ae5a8b8-deed-4007-8753-c6c7b04b715d

Violation Codes3

21 CFR 600.12(a)21 CFR 606.100(b)21 CFR 606.60(a)

Full citation text and observation details available on the Dashboard.